Cargando…

Zanamivir versus trivalent split virus influenza vaccine: a pilot randomized trial

BACKGROUND: Healthcare workers may be exposed to people with respiratory viral infections more often than other working adults. Understanding the risk and the effectiveness of different preventive measures is of great importance. OBJECTIVES: To estimate adherence to prophylactic antiviral medication...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coleman, Brenda L, Fadel, Shaza A, Drews, Steven J, Hatchette, Todd F, McGeer, Allison J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353320/ https://www.ncbi.nlm.nih.gov/pubmed/25557838 http://dx.doi.org/10.1111/irv.12301

Ejemplares similares

Respiratory illnesses in Canadian health care workers: a pilot study of influenza vaccine and oseltamivir prophylaxis during the 2007/2008 influenza season
por: Coleman, Brenda L., et al.
Publicado: (2011)

Intravenous zanamivir for influenza myocarditis and enteral malabsorption
por: Jahns, Fritz-Patrick, et al.
Publicado: (2018)

Association of Influenza Activity and Environmental Conditions With the Risk of Invasive Pneumococcal Disease
por: Berry, Isha, et al.
Publicado: (2020)

Risk factors for serious outcomes associated with influenza illness in high‐ versus low‐ and middle‐income countries: Systematic literature review and meta‐analysis
por: Coleman, Brenda L., et al.
Publicado: (2017)

Comparison of efficacy and safety of oseltamivir and zanamivir in pandemic influenza treatment
por: Tuna, Nazan, et al.
Publicado: (2012)

Burden of severe illness associated with laboratory confirmed influenza in adults aged 50–64 years: A rapid review
por: Kim, Dong Kyu, et al.
Publicado: (2022)

531 Split-virion compared to Subunit Influenza Trivalent Influenza Vaccines Has Greater Effectiveness in Older Adults
por: Talbot, H. Keipp, et al.
Publicado: (2014)

Risk Factors for Influenza among Health Care Workers during 2009 Pandemic, Toronto, Ontario, Canada
por: Kuster, Stefan P., et al.
Publicado: (2013)

Self-Collected Mid-Turbinate Swabs for the Detection of Respiratory Viruses in Adults with Acute Respiratory Illnesses
por: Larios, Oscar E., et al.
Publicado: (2011)

Safety and tolerability of a 2009 trivalent inactivated split‐virion influenza vaccine in infants, children and adolescents
por: Lambert, Stephen B., et al.
Publicado: (2013)

Zanamivir for the prevention of influenza in adults and children age 5 years and older
por: Eiland, Lea S, et al.
Publicado: (2007)

Zanamivir should be inhaled, not nebulised
por: Eagel, Barry A
Publicado: (2010)

Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
por: You, Joyce HS, et al.
Publicado: (2014)

The Clinical Impact and Cost Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in Finland
por: Nagy, Lisa, et al.
Publicado: (2016)

Comparison of response rates on invitation mode of a web-based survey on influenza vaccine adverse events among healthcare workers: a pilot study
por: Tai, Xiaochen, et al.
Publicado: (2018)

Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments
por: Heneghan, Carl J, et al.
Publicado: (2014)

Molecular modeling and lead design of substituted zanamivir derivatives as potent anti-influenza drugs
por: Dholakia, Dhwani, et al.
Publicado: (2016)

Surveillance on the Immune Effectiveness of Quadrivalent andTrivalent Split Influenza Vaccines — Shenzhen Cityand Changzhou City, China, 2018–2019
por: Shu, Liumei, et al.
Publicado: (2020)

Influenza B vaccine lineage selection—An optimized trivalent vaccine
por: Mosterín Höpping, Ana, et al.
Publicado: (2016)

Incidence of Influenza in Healthy Adults and Healthcare Workers: A Systematic Review and Meta-Analysis
por: Kuster, Stefan P., et al.
Publicado: (2011)

Factors associated with influenza vaccination among healthcare workers in acute care hospitals in Canada
por: Hussain, Hadia, et al.
Publicado: (2018)

Cost Effectiveness of Quadrivalent Versus Trivalent Inactivated Influenza Vaccines for the Portuguese Elderly Population
por: Tavares, Diana, et al.
Publicado: (2022)

Long-term follow-up in patients with HIV vaccinated with pandemic influenza A(H1N1)/09 AS03-adjuvanted split virion vaccine and seasonal trivalent influenza split virion vaccine
por: Pauksens, Karlis
Publicado: (2013)

Acquired immune responses to the seasonal trivalent influenza vaccination in COPD
por: Staples, K. J., et al.
Publicado: (2019)

The Intranasal Application of Zanamivir and Carrageenan Is Synergistically Active against Influenza A Virus in the Murine Model
por: Morokutti-Kurz, Martina, et al.
Publicado: (2015)

A Review of Clinical Influenza A and B Infections With Reduced Susceptibility to Both Oseltamivir and Zanamivir
por: Abed, Yacine, et al.
Publicado: (2017)

Zanamivir aqueous solution in severe influenza: A global Compassionate Use Program, 2009–2019
por: Wang‐Jairaj, Jie, et al.
Publicado: (2021)

Persistent Functional Decline Following Hospitalization with Influenza or Acute Respiratory Illness
por: Andrew, Melissa K., et al.
Publicado: (2020)

Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults
por: Spencer, Sarah, et al.
Publicado: (2021)

Neuraminidase Inhibitor Zanamivir Ameliorates Collagen-Induced Arthritis
por: Sehnert, Bettina, et al.
Publicado: (2021)

Lessons from resistance analysis in clinical trials of IV zanamivir
por: Yates, Phillip J, et al.
Publicado: (2023)

Permeability Enhancers Dramatically Increase Zanamivir Absolute Bioavailability in Rats: Implications for an Orally Bioavailable Influenza Treatment
por: Holmes, Eric H., et al.
Publicado: (2013)

Study of Oseltamivir and Zanamivir Resistance-Related Mutations in Influenza Viruses Isolated from Wild Mallards in Sweden
por: Orozovic, Goran, et al.
Publicado: (2014)

Population Pharmacokinetic/Pharmacodynamic Analysis of Intravenous Zanamivir in Healthy Adults and Hospitalized Adult and Pediatric Subjects With Influenza
por: Zuo, Peiying, et al.
Publicado: (2019)

25. Relative Effectiveness of Adjuvanted Trivalent Influenza Vaccine Compared to Egg-Based Trivalent High-Dose Influenza Vaccine among U.S. Older Adults during 2019-20 Influenza Season
por: levin, myron J, et al.
Publicado: (2021)

Gulllain-Barre Syndrome After Trivalent Influenza Vaccination in Adults
por: Chang, Kuo-Hsuan, et al.
Publicado: (2019)

Assessment of trivalent live influenza vaccines in MDCK cell line
por: Landgraf, G., et al.
Publicado: (2021)

Effectiveness of the MF59‐adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta‐analysis
por: Coleman, Brenda L., et al.
Publicado: (2021)

Immunogenicity and safety of quadrivalent versus trivalent inactivated influenza vaccine: a randomized, controlled trial in adults
por: Beran, Jiří, et al.
Publicado: (2013)

Immunogenicity and Safety of Trivalent Split Influenza Vaccine in Healthy Korean Adults with Low Pre-Existing Antibody Levels: An Open Phase I Trial
por: Kang, Kyuri, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_p85jvp0b8qriqsnji2v9q8aj5n